Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 2678

Professor Nita Farahany reveals to Azeem Azhar the startling advancements of brain-scanning technology and the extraordinary implications this tech has for privacy and humanity.

——-
Like this video? Subscribe: https://www.youtube.com/Bloomberg?sub_confirmation=1
Become a Quicktake Member for exclusive perks: https://www.youtube.com/bloomberg/join.

Bloomberg Originals offers bold takes for curious minds on today’s biggest topics. Hosted by experts covering stories you haven’t seen and viewpoints you haven’t heard, you’ll discover cinematic, data-led shows that investigate the intersection of business and culture. Exploring every angle of climate change, technology, finance, sports and beyond, Bloomberg Originals is business as you’ve never seen it.

Subscribe for business news, but not as you’ve known it: exclusive interviews, fascinating profiles, data-driven analysis, and the latest in tech innovation from around the world.

Continue reading “Inside Mind-Reading AI” | >

Would hope this means we dont Need to reverse engineer and are done w/ the brains of insects. From here, id like to see done in about following order, reverse engineer brains of: 1. Mice, 2. Lab Rats, 3. Crows (small brains, but supposedly smarter than chimps) 4. Octopi, 5. Pigs, 6. Chimps, and 7. and end on the human brain. Would hope we can do work on each in the build up to human brains, mainly tec it will require to reverse engineer all mentioned. Maybe it leads no where, or maybe we need it all to solve Agi. Also, aim for completion by 12/31/2029. Wanted to add, i believe should be an international effort: US, Canada, EU, Israel, Korea, Japan, etc… instead of just being a US project.

By Anne J. Manning Harvard Staff Writer.

Date September 26, 2023 September 27, 2023.

Read more | >

Scientists have captured the fleeting moment when a heart starts beating, a feat made all the more remarkable when you consider the relative brevity of a zebrafish’s life.

In a tight window about 20 hours into zebrafish development, the embryos’ developing hearts jumped into action, emerging as one from an ensemble of single cells.

“It was like somebody had flipped on a switch,” says Harvard University biophysicist Adam Cohen, senior author of the new study, which imaged zebrafish embryos snug in custom-made agarose molds to capture this once-in-a-lifetime event.

Read more | >

Using their new scaffold with cryo-EM, the UCLA-led team saw the atomic structure of KRAS when it was connected to a drug being studied for lung cancer treatment. This showed that their method can help understand how drugs interact with proteins like KRAS, potentially leading to better medicines.

Castells-Graells said, “The potential applications for the new advance don’t stop with cancer drugs. ” Our modular scaffold can be assembled in any configuration to capture and hold all small protein molecules.”

The UCLA-led team’s essential improvement to cryo-EM technology represents a significant milestone in structural biology and scientific imaging. Their achievement in visualizing small therapeutic protein targets at 3 Å resolution is a testament to the power of innovation and collaboration in pushing the boundaries of scientific discovery. This breakthrough promises to revolutionize drug development and our understanding of complex biological systems, further solidifying Cryo-EM’s place as an invaluable tool in modern research.

Read more | >

How well that translation occurs remains to be seen while the patient learns and adapts to the new system. “The implant procedures involving the Onward ARC-IM and Clinatec BCI went smoothly,” Dr. Bloch said in an press release. “We are now working with the patient to use this cutting-edge innovation to recover movement of his arms, hands, and fingers. We look forward to sharing more information in due course.”

“If the therapy continues to show promise, it is possible it could reach patients by the end of the decade,” Onward CEO Dave Marver said in a statement to Engadget. “It is important to note that we do not expect people with spinal cord injury to wait that long for Onward to commercialize an impactful therapy — we hope to commercialize our external spinal cord stimulation solution, ARC-EX Therapy, to restore hand and arm function in the second half of 2024.”

Onward Medical among a quickly expanding field of BCI-based startups working to apply the fledgling technology to a variety of medical maladies. Those applications include loss of limb and self-regulatory function due to stroke, traumatic brain or spinal cord injury, physical rehabilitation from those same injuries, as well as a critical means of communication for people living with Locked-In Syndrome.

Read more | >